— Net sales increase 16% to a record $9.9 million, EPS $0.02 vs. $0.00 — KAILUA-KONA, Hawaii (November 10, 2016) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the second quarter and first six months of fiscal year 2017, ended September 30,... Read More

KAILUA-KONA, Hawaii (October 25, 2016) — The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Nancy Katz as a Director of the Company. “We are pleased to welcome Ms. Katz to Cyanotech’s Board,” said Michael A. Davis, Chairman of the Board. “Her significant experience as an executive and director of public companies... Read More

KAILUA-KONA, Hawaii–(BUSINESS WIRE)–Cyanotech® Corporation (Nasdaq Capital Market: CYAN), is proud to announce that its bulk raw material BioAstin® SCE products have received Non-GMO Project Verification. BioAstin Natural Astaxanthin is a potent natural antioxidant that provides natural support for joint, skin, eye and brain health.* BioAstin is derived from natural microalgae, Haematococcus pluvialis, cultivated and grown... Read More